Home / BUSINESS / USFDA conducts inspection at Biocon’s Bengaluru facility

USFDA conducts inspection at Biocon’s Bengaluru facility

United States Food and Drug Administration (USFDA) has conducted a pre-approval inspection of Biocon’s new Oral Solid Dosage Forms manufacturing facility at Bengaluru from November 05 to 09. The audit concluded without any observations and no Form 483 was issued.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient’s worldwide.

Please share this news

Check Also

Flipkart adds over 14,000 kiranas for delivery in Northern India ahead of the festive season

Udaipur :  In preparation of the upcoming festive season and the Big Billion Days, Flipkart, India’s …